Prostatitis is associated with inflammation (and or neural upregulation or sensitization), and in a few cases, infection of the prostate, causing pain in the prostate and pelvic area along with variable urinary symptoms. Acute bacterial prostatitis is rare, quite severe, relatively simple to diagnose, and quite easy to cure with...

Prostate cancer is highly curable when it is identified at an early stage. The PSA blood test, although not foolproof, improves the chance of arresting cancer while it’s still contained within the prostate. Detecting prostate cancer early gives men...
 

WANT TO LEARN THE BASICS
OF PROSTATE CANCER?
WE HAVE A PROSTATE CANCER 101
ANIMATED VIDEO SERIES ON OUR WEBSITE! 

PCRI's free Helpline connects patients and caregivers with educational advocates and helps them understand their personal case. This article is a top ten frequently asked questions list that our Helpline receives. 

Prostate size is an additional factor besides Gleason score, PSA, and the percentage of core biopsies involved with cancer, that needs to be considered when going through the treatment selection process.

A new oral medication called ARAMIS is being evaluated in men who have rising PSA levels on Lupron and whose bone scans remain clear. For more information, visit: https://clinicaltrials.gov/show/NCT02200614

ARAMIS is similar to Xtandi but may have some advantages because ARAMIS is less likely to affect brain function which could reduce the likelihood of seizures and side effects...

Ken Griffey Sr. is a three-time baseball all-star, a prostate cancer survivor, and a spokesperson for Bayer’s Men Who Speak Up program, which encourages men with advanced prostate cancer to know the symptoms of progressing disease and offers resources to help them feel more comfortable speaking up about it. Mr. Griffey, who is conducting a nationwide Men Who Speak Up tour with his son, Hall-of-Famer Ken Griffey Jr., will be a guest speaker at the 2016 Prostate Cancer Conference on September 10.

This is a letter that we received from a recent helpline caller. It demonstrates the critical importance of support empowerment and information and how it prepares you for partnership with your medical professionals. This letter was published with permission from its author.

"Researchers are hopeful about the potential for a novel agent in high-risk prostate cancer" states Tony Berberabe, MPh in his published article for Cure Magazine on June 23rd, 2016

AUA is an annual meeting of urologists where data from new studies are presented. This data is presented in abstracts, or summaries of the entire peer reviewed articles. In this article, Mark Scholz, MD, analyzes the data and explains the practical implications of these new studies.